Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
   
Ask the Experts About

Choosing Your MedsChoosing Your Meds
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


what about HIV-2?
May 18, 2012

Lots of research is being done to control HIV-1. What about HIV-2? Because of its long incubation period, limited treatment options and silent spread, it is going to be more dangerous than HIV-1 in 2 decades or less. Even NNRTIs and few other drugs are ineffective. So whats the solution for HIV-2? regards.

Response from Dr. Young

Hello and thanks for posting.

I wouldn't forecast that HIV-2 is going to be worse than HIV-1. It far less common, causes far less serious and less rapid disease.

While admittedly, there's less focus on treatment for HIV-2, there is a quite large range of treatments. Nevertheless, getting people in care and all the issues of adherence and drug resistance remain problematic.

BY



Previous
HIV symptoms lasting over 3 months?
Next
Can HIV be transmitted to other partner during PEP?

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement